Enhancement of antipsychotic-like effects by combined treatment with the α1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats

Journal of Neural Transmission

Volumn 107, Issue 10, 2000, Pages 1229-1238

  Wadenberg, M L ^a   Hertel, P ^a   Fernholm, R ^a   Hygge Blakeman, K ^a   Ahlenius, S ^a   Svensson, T H ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

1 adrenoceptors; Conditioned avoidance; Dopamine D2 receptors; Rat

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; PRAZOSIN; RACLOPRIDE;

ADRENERGIC RECEPTOR BLOCKING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVOIDANCE BEHAVIOR; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; EXTRAPYRAMIDAL SYMPTOM; MALE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; PSYCHOSIS; RAT; RECEPTOR OCCUPANCY;

ANIMALS; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; CATALEPSY; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; PRAZOSIN; PSYCHOTIC DISORDERS; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, DOPAMINE D2;

EID: 0033777513     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020070036     Document Type: Article

References (32)

1. Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: A comparison between the effects produced by pre- and postsynaptic inhibition of dopaminergic neurotransmission
2. Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not the nigrostriatal dopaminergic system
3. Pharmacological specificity of conditioned avoidance response inhibition in rats: Inhibition by neuroleptics and correlation to dopamine receptor blockade
4. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence
5. Further studies of the mechanism behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in rats
6. 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection
7. 1 adrenoceptor stimulation
8. The current status of the dopamine hypothesis of schizophrenia
9. The pharmacology of prazosin, a novel antihypertensive agent
10. 2 receptors: Implications for drug mechanism of action
11. Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats
12. New antipsychotics: The present status
13. Prazosin modulates the firing pattern of dopaminergic neurons in rat ventral tegmental area
14. 1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic patients
15. Norepinephrine in acute exacerbations of chronic schizophrenia
16. 2 receptors in the rat brain
17. Schizophrenia: Elevated cerebrospinal fluid norepinephrine
18. 1-noradrenergic receptors demonstrated by in vivo voltammetry
19. Electrophysiologic interactions of antipsychotic drugs with central noradrenergic pathways
20. Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens
21. Relationship of neuroleptic drug effects at brain dopamine, serotonin, α-adrenergic, and histamine receptors to clinical potency
22. Effects of dopamine antagonists in a two-way active avoidance procedure in rats: Interactions with 8-OH-DPAT, ritanserin, and prazosin
23. 1-adrenoceptor antagonism
24. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia
25. 1-adrenergic receptor subtype to the expression of the 'ventral tegmental area syndrome'
26. Antipsychotic-like profile of combined treatment with raclopride and 8-OH-DPAT in the rat: Enhancement of antipsychotic-like effects without catalepsy
27. The conditioned avoidance response test re-evaluated: Is it a sensitive test for the detection of potentially atypical antipsychotics?
28. Suppression of conditioned avoidance behavior by the local application of (-)sulpiride into the ventral, but not the dorsal, striatum of the rat
29. 2 receptor blocking agent ritanserin in the rat
30. Enhancement of antipsychotic-like properties of raclopride in rats using the selective serotonin(2A) receptor antagonist MDL 100,907